BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials

BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials

Submitted by admin on October 3, 2023 - 10:20am
Source: 
Biopharma Reporter
News Tags: 
BPGbio
artificial intelligence
pancreatic cancer
BPM 31510
clinical trials
Headline: 
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
snippet: 

BPGbio, an AI-powered biopharma that focuses on oncology, neurology, and rare diseases, is advancing its pancreatic cancer drug BPM 31510 IV after a positive phase 1 and 2a study.

Do Not Allow Advertisers to Use My Personal information